E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/29/2012 in the Prospect News PIPE Daily.

Innovus Pharmaceuticals completes $100,500 private placement of stock

Company offers 134,000 of its common shares at $0.75 apiece in deal

By Devika Patel

Knoxville, Tenn., June 29 - Innovus Pharmaceuticals, Inc. settled a $100,500 private placement of stock on June 26, according to an 8-K filed Friday with the Securities and Exchange Commission.

The company sold 134,000 common shares at $0.75 apiece. The price per share is a 72.43% discount to the June 25 closing share price of $2.72.

The pharmaceutical company is based in Sierra Madre, Calif.

Issuer:Innovus Pharmaceuticals, Inc.
Issue:Common shares
Amount:$100,500
Shares:134,000
Price:$0.75
Warrants:No
Settlement date:June 26
Stock symbol:OTCBB: INNV
Stock price:$2.72 at close June 25
Market capitalization:$44.02 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.